Predictive Oncology Inc.
POAI
$0.96
-$0.03-3.03%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 32.91% | 11.56% | 28.74% | 43.71% | 54.95% |
| Total Depreciation and Amortization | 6.28% | -4.87% | 11.18% | -22.84% | -30.70% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 23.97% | -88.63% | -92.64% | -92.85% | -96.39% |
| Change in Net Operating Assets | -7.60% | 76.62% | -89.91% | -97.07% | -64.92% |
| Cash from Operations | 53.54% | 33.41% | 27.17% | 0.95% | -3.72% |
| Capital Expenditure | 97.32% | 96.41% | 101.78% | 101.29% | 39.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5,352.10% | 100.00% | 74.05% | 82.52% | 72.45% |
| Cash from Investing | 339.08% | 96.86% | 99.41% | 98.81% | 41.48% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.22% | -215.30% | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | 93.64% | 94.57% | 94.57% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 15,415.07% | 1,948.96% | 1,225.19% | 12,402.90% | -99.45% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 101.18% | 56.97% | 51.16% | 30.06% | -105.57% |